Mon. 11 Mar 2024, 4:22pm ET
Benzinga
Earnings, News
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 11.36 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $3.56 million which missed the analyst consensus estimate of $4.61 million by 22.82 percent. This is a 3.63 percent decrease over sales of $3.69 million the same period last year.